cover image - Diabeto-Cardiology, 2nd Edition
ISBN: 9780323878623
Copyright: 2025
Page Count: 416
Imprint: Saunders
List Price: $220.99

Diabeto-Cardiology, 2nd Edition

by Darren K McGuire, MD, PLLC and Nikolaus Marx, MD, FESC, FAHA

Hardcover

cover image - Diabeto-Cardiology, 2nd Edition
ISBN: 9780323878623
Copyright: 2025
Page Count: 416
Imprint: Saunders
List Price: $220.99
Not Yet Available
Coming Soon!
Expected availability date: 03-01-2025
    • Combines coverage of the latest understanding of the complex relationship between diabetes and cardiology with all the recent clinical advances
    • Practical and concise presentation with focus on actionable clinical content
    • Includes the newest antidiabetic drugs that are cardioprotective, MACE, heart failure, the latest clinical trials, and treatment revolutions of therapy in both specialty areas of practice
    • Features new Clinical Practice Points and Take Home Summaries
    • Leading team of experts in cardiology and diabetes for cutting edge, definitive content
  • Includes the newest antidiabetic drugs that are cardioprotective, MACE, heart failure, the latest clinical trials, and treatment revolutions of therapy in both specialty areas of practice

    New Clinical Practice Points and Take Home Summaries

  • Section 1 Diabetes Mellitus

    1. Definition and Epidemiology of Type 2 Diabetes Mellitus

    2. Insulin Resistance: Pathophysiology, Molecular Mechanisms, Genetic Insights

    3. Lifestyle Interventions for the Prevention of Type 2 Diabetes Mellitus

    4. Pharmacological and Surgical Interventions That Prevent or Remit Type 2 Diabetes

    5. Type 1 Diabetes: Pathophysiology and Treatment Considerations for Cardiovascular Risk and Disease

    Section 2 Cardiovascular Complications of Type 2 Diabetes

    6. Atherosclerosis in Patients with Type 2 Diabetes: Epidemiology

    7. Pathology and Vascular Biology of Atherosclerosis in Patients with Type 2 Diabetes: Inflammation, Dyslipidemia, Hypercoagulability, Endothelial Dysfunction, and Inflammation

    8. Risk Stratification Among Patients with Type 2 Diabetes with or at Risk for Atherosclerotic Cardiovascular Disease

    9. Epidemiology and Pathophysiology of Heart Failure with Preserved and with Reduced Ejection Fraction in Patients with Type 2 Diabetes

    Section 3 Effects of Antihyperglycemic Therapies for Type 2 Diabetes on Cardiovascular and Kidney Outcomes

    10. Effect of Acute and Chronic Glucose Management on Coronary Heart Disease Risk in Patients with Type 2 Diabetes

    11. Regulatory Approach to Medications for Type 2 Diabetes: Past, Present and Future

    12. Cardiovascular and Kidney Effects of Sodium Glucose Co-transporter Inhibitors

    13. Cardiovascular and Kidney Effects of Glucagon-like Peptide 1 Receptor Agonists

    14. Antihyperglycemic Medications with Proven Cardiovascular Safety

    15. Prevention of Heart Failure in Patients with Type 2 Diabetes

    16. Treatment of Patients with Reduced and with Preserved Ejection Fraction Heart Failure in Patients with Type 2 Diabetes

    Section 4 Management of Coronary Heart Disease Risk, Chronic and Acute Coronary Syndromes in Patients with Type 2 Diabetes

    17. Effect of Lifestyle Interventions on Coronary Heart Disease Risk in Patients with Type 2 Diabetes

    18. Effect of Blood Pressure Management on Coronary Heart Disease Risk in Patients with Type 2 Diabetes

    19. Effect of Lipid Management on Coronary Heart Disease Risk in Patients with Type 2 Diabetes

    20. Effect of Antiplatelet and Anticoagulant Therapies on Coronary Heart Disease Risk in Patients with Type 2 Diabetes

    21. Therapeutic Implications of Type 2 Diabetes for Patients Undergoing Percutaneous or Surgical Coronary Revascularization

    22. Epidemiology of Acute Coronary Syndromes in Patients with Type 2 Diabetes

    23. Antiplatelet and Anticoagulant Therapy in Patients with Type 2 Diabetes with Acute Coronary Syndromes and/or Percutaneous Coronary Intervention

    Section 5 Other Cardiovascular Considerations Associated with Type 2 Diabetes

    24. Peripheral Artery Disease in Patients with Type 2 Diabetes

    25. Cerebrovascular Disease in Patients with Type 2 Diabetes

    26. Atrial Fibrillation in Patients with Type 2 Diabetes

    27. Chronic Kidney Disease: Implications for Cardiovascular Risk and Management in Patients with Type 2 Diabetes

    28. Disparities in Type 2 Diabetes Risk, Cardiovascular Consequences, and Care: Women, Race/Ethnic Minorities, and the Elderly

    29. The Quality Chasm – Type 2 Diabetes

  • Darren K McGuire, MD, PLLC, Professor, Department of Internal Medicine, Dallas Heart Ball Chair for Research on Heart Disease in Women, University of Texas Southwestern Medical Center, Director, Outpatient Cardiology Clinic, Parkland Hospital and Health System, Dallas, Texas and Nikolaus Marx, MD, FESC, FAHA, Professor of Medicine/Cardiology, Head of Department of Internal Medicine I, University Hospital Aachen, Aachen, Germany
Not Yet Available
Coming Soon!
Expected availability date: 03-01-2025